Skip to main navigation Skip to search Skip to main content

Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma

  • Wei Liu
  • , Juan Chen
  • , Archito T. Tamayo
  • , Changgeng Ruan
  • , Li Li
  • , Shouhao Zhou
  • , Chan Shen
  • , Ken H. Young
  • , Jason Westin
  • , Richard E. Davis
  • , Shimin Hu
  • , Leonard J. Medeiros
  • , Richard J. Ford
  • , Lan V. Pham

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science